Headache in the international cohort study of mobile phone use and health (COSMOS) in the Netherlands and the United Kingdom.

COSMOS Cohort study Headache Migraine Mobile phone use Radiofrequency electromagnetic fields (RF-EMFs)

Journal

Environmental research
ISSN: 1096-0953
Titre abrégé: Environ Res
Pays: Netherlands
ID NLM: 0147621

Informations de publication

Date de publication:
01 May 2024
Historique:
received: 14 10 2023
revised: 13 01 2024
accepted: 20 01 2024
medline: 19 4 2024
pubmed: 28 1 2024
entrez: 27 1 2024
Statut: ppublish

Résumé

Headache is a common condition with a substantial burden of disease worldwide. Concerns have been raised over the potential impact of long-term mobile phone use on headache due to radiofrequency electromagnetic fields (RF-EMFs). We explored prospectively the association between mobile phone use at baseline (2009-2012) and headache at follow-up (2015-2018) by analysing pooled data consisting of the Dutch and UK cohorts of the Cohort Study of Mobile Phone Use and Health (COSMOS) (N = 78,437). Frequency of headache, migraine, and information on mobile phone use, including use of hands-free devices and frequency of texting, were self-reported. We collected objective operator data to obtain regression calibrated estimates of voice call duration. In the model mutually adjusted for call-time and text messaging, participants in the high category of call-time showed an adjusted odds ratio (OR) of 1.04 (95 % CI: 0.94-1.15), with no clear trend of reporting headache with increasing call-time. However, we found an increased risk of weekly headache (OR = 1.40, 95 % CI: 1.25-1.56) in the high category of text messaging, with a clear increase in reporting headache with increasing texting. Due to the negligible exposure to RF-EMFs from texting, our results suggest that mechanisms other than RF-EMFs are responsible for the increased risk of headache that we found among mobile phone users.

Identifiants

pubmed: 38280529
pii: S0013-9351(24)00194-4
doi: 10.1016/j.envres.2024.118290
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

118290

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Eugenio Traini (E)

Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands. Electronic address: e.traini@uu.nl.

Rachel B Smith (RB)

MRC Centre for Environment and Health, School of Public Health, Imperial College London, UK; NIHR Health Protection Research Unit in Chemical and Radiation Threats and Hazards, School of Public Health, Imperial College London, UK; Mohn Centre for Children's Health and Wellbeing, School of Public Health, Imperial College London, UK; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, UK.

Roel Vermeulen (R)

Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands.

Hans Kromhout (H)

Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands.

Joachim Schüz (J)

International Agency for Research on Cancer (IARC/WHO), Environment and Lifestyle Epidemiology Branch, Lyon, France.

Maria Feychting (M)

Karolinska Institutet, Institute of Environmental Medicine, Stockholm, Sweden.

Anssi Auvinen (A)

STUK - Radiation and Nuclear Safety Authority, Environmental Radiation Surveillance, Helsinki, Finland; Tampere University, Faculty of Social Sciences, Tampere, Finland.

Aslak Harbo Poulsen (AH)

The Danish Cancer Institute, Copenhagen, Denmark.

Isabelle Deltour (I)

International Agency for Research on Cancer (IARC/WHO), Environment and Lifestyle Epidemiology Branch, Lyon, France.

David C Muller (DC)

MRC Centre for Environment and Health, School of Public Health, Imperial College London, UK; NIHR Health Protection Research Unit in Chemical and Radiation Threats and Hazards, School of Public Health, Imperial College London, UK; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, UK; Cancer Epidemiology and Prevention Research Unit, School of Public Health, Imperial College London, UK.

Joël Heller (J)

MRC Centre for Environment and Health, School of Public Health, Imperial College London, UK; NIHR Health Protection Research Unit in Chemical and Radiation Threats and Hazards, School of Public Health, Imperial College London, UK; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, UK.

Giorgio Tettamanti (G)

Karolinska Institutet, Institute of Environmental Medicine, Stockholm, Sweden.

Paul Elliott (P)

MRC Centre for Environment and Health, School of Public Health, Imperial College London, UK; NIHR Health Protection Research Unit in Chemical and Radiation Threats and Hazards, School of Public Health, Imperial College London, UK; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, UK.

Anke Huss (A)

Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands.

Mireille B Toledano (MB)

MRC Centre for Environment and Health, School of Public Health, Imperial College London, UK; NIHR Health Protection Research Unit in Chemical and Radiation Threats and Hazards, School of Public Health, Imperial College London, UK; Mohn Centre for Children's Health and Wellbeing, School of Public Health, Imperial College London, UK; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH